CONTINUOUS GLUCOSE MONITORING (CGM) PADA KEGAWATDARURATAN DIABETES MELLITUS (HIPOGLIKEMIA): LITERATURE REVIEW

Nurul Hidayah; Robiul Fitri  Masithoh

Nurul Hidayah Universitas Muhammadiyah Magelang
Robiul Fitri Masithoh Universitas Muhammadiyah Magelang

Keywords: Continuous Glucose Monitoring, Emergency, Diabetes Mellitus, Hypoglycemia

Abstract

Continuous Glucose Monitoring (CGM) is a tool to detect blood glucose levels in Diabetes Mellitus patients, and in this case also causes hypoglycemia. Hypoglycemia is an emergency that must be treated immediately. Patients who have emergency conditions such as hypoglycemia should have their blood glucose levels monitored. The purpose of this study was to determine the use of Continuous Glucose Monitoring (CGM) in Diabetes Mellitus (Hypoglycemia) emergencies. There are several types of Continuous Glucose Monitoring (CGM) offered by several distributors, but these types have the same function, which is to help patients, their families, and the health team to determine the patient's current health condition. This research method uses a literature review study using PubMed, ScienceDirect, ProQuest, and ClinicalKey. The results of the study contained 5 articles that matched the inclusion and exclusion criteria of the researcher.

Downloads

Download data is not yet available.

References

Armalia, N. & Herawati, T. (2020). Continuous Glucose Monitoring System (CGMS) Pada Penderita Diabetes Mellitus: Tinjauan Literatur. REAL in Nursing Journal (RNJ); 3 (2): 95-105.

Cappon, G., Vettoretti, M., Sparacino, G., & Facchinetti, A. (2019). Continuous Glucose Monitoring Sensors for Diabetes Management: A Review of Technologies and Applications. Diabetes and Metabolism Journal; (43):383-397. https://doi.org/10.4093/dmj.2019.0121. pISSN 2233-6079. eISSN 2233-6087.

Chamberlain, J.J., Dopita, D., Gilgen, E., & Neuman, A. (2016). Impact of Frequent and Persistent Use of Continuous Glucose Monitoring (CGM) on Hypoglycemia Fear, Frequency of Emergency Medical Treatment, and SMBG Frequency After One Year. Journal of Diabetes Science and Technology; 10(2): 383–388. DOI: 10.1177/1932296815604633.

Chehregosha, H., Khamseh, M.E., Malek, M., Hosseinpanah, F., & Beigi, F.I. (2019). A View Beyond HbA1c: Role of Continuous Glucose Monitoring. Diabetes Ther 10, 853–863. https://doi.org/10.1007/s13300-019-0619-1.

Didyuk, O., Econom, N., Guardia, A., Livingston, K., & Klueh, U. (2021). Continuous Glucose Monitoring Devices: Past, Present, and Future Focus on the History and Evolution of Technological Innovation. Journal of Diabetes Science and Technology; 15 (3): 676-683. https://doi.org/10.1177/1932296819899394.

Geller, A.I., Shehab, N., & Lovegrove, M.C. (2014). National Estimates of Insulin-Related Hypoglycemia and Errors Leading to Emergency Department Visits and Hospitalizations. JAMA Intern Med;174(5):678-686. doi:10.1001/jamainternmed.2014.136.

Hajime, M., Okada, Y., Mori, H., Uemura, F., Sonoda, S., Tanaka, K., Kurozumi, A., Narisawa, M., Torimoto, K., & Tanaka, Y. (2019). Hypoglycemia in Blood Glucose Level in Type 2 Diabetic Japanese Patients by Continuous Glucose Monitoring. Diabetol Metab Syndr; 11:18. https://doi.org/10.1186/s13098-019-0412-3.

International Diabetes Federation. (2015). IDF Diabetes Atlas Seventh Edition. Brussels, Belgium: International Diabetes Federation.

Klonoff, D.C., Ahn, D., & Drincic, A. (2017). Continuous Glucose Monitoring: A Review of The Technology and Clinical Use. Diabetes Research and Clinical Practice, 133: 178-192. https://doi.org/10.1016/j.diabres.2017.08.005.

Moser, O., Pandis, M., Aberer, F., Kojzar, H., Hochfellner, D., Elsayed, H., Motschnig, M., Augustin, T., Kreuzer, P., Pieber, T.R., Sourij, H., & Mader, J.K. (2018). A Head-to-Head Comparison of Personal and Professional Continuous Glucose Monitoring Systems in People with Type 1 Diabetes: Hypoglycaemia remains The Weak Spot. Diabetes Obes Metab; 21: 1043-1048. DOI: 10.1111/dom.13598.

Perkumpulan Endokrinologi Indonesia. (2015). Panduan Penatalaksanaan DM Tipe 2 pada Individu Dewasa di Bulan Ramadan. Jakarta: PB. Perkeni.

Pratley, R.E., Kanapka, L.G., Rickels, M.R., Ahmann, A. Aleppo, G., Beck, R., Bhargava, A., Bode, B.W., Carlson, A. Chaytor, N.S., Fox, D.S., Goland, R., Hirsch, I.B., Kruger, D., Kudva, Y.C., Levy, C., McGill, J.B., Peters, A., Philipson, L., Tsimikas, A.P., Busui, R.P., Shah, V.N., Thompson, M., Vendrame, F., Verdejo, A., Weinstock, R.S., Young, L., & Miller, K.M. (2020). Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults with Type 1 Diabetes A Randomized Clinical Trial. JAMA; 323(23):2397-2406. doi:10.1001/jama.2020.6928.

Prendin, F., Favero, S.D., Vettoretti, M., Sparacino, G., & Facchinetti, A. (2021). Forecasting of Glucose Levels and Hypoglycemic Events: Head-to-Head Comparison of Linear and Nonlinear Data-Driven Algorithms Based on Continuous Glucose Monitoring Data Only. Sensors; 21, 1647. https://doi.org/10.3390/s21051647.

Rowley, W.R., Bezold, C., Arikan, Y., Byrne, E., & Krohe, K. (2017). Diabetes 2030: Insights from Yesterday, Today, and Future Trends. Population Health Management; 20 (1): 6-12. https://doi.org/10.1089/pop.2015.0181.

Rusdi, M.S. (2020). Hipoglikemia pada Pasien Diabetes Melitus. Journal Syifa Sciences and Clinical Research; 2 (2): 83-90.

Seaquist, E.R., Anderson, J., Childs, B., Cryer, P., Dagogo-Jack, S., Fish, L., Heller, S.R., Rodriguez, H., Rosenzweig, J., & Vigersky, R. (2013). Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society. Diabetes Care. 36 (5) 1384-1395; DOI: 10.2337/dc12-2480.

Umpierrez, G. & Korytkowski, M. (2016). Diabetic Emergencies - Ketoacidosis, Hyperglycaemic Hyperosmolar State and Hypoglycaemia. Nat Rev Endocrinol; 12(4): 222-32. doi: 10.1038/nrendo.2016.15.

World Health Organization. (2016). Global Status Report on Noncommunicable Diseases 2010. Description of The Global Burden of Ncds, Their Risk Factors and Determinants. 2011. Google Scholar.

Yale, J.F., Paty, B., & Senior, P.A. (2018). Clinical Practice Guidelines Hypoglycemia Diabetes Canada Clinical Practice Guidelines Expert Committee. Can J Diabetes 42: S104–S108.